Comparison of hydroxychloroquine, lopinavir/ritonavir, and standard of care in critically ill patients with SARS-CoV-2 pneumonia: an opportunistic retrospective analysis

BACKGROUND: The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) outbreak is spreading worldwide. To date, no specific treatment has convincingly demonstrated its efficacy. Hydroxychloroquine and lopinavir/ritonavir have potential interest, but virological and clinical data are scarce, e...

Descripción completa

Detalles Bibliográficos
Autores principales: Lecronier, Marie, Beurton, Alexandra, Burrel, Sonia, Haudebourg, Luc, Deleris, Robin, Le Marec, Julien, Virolle, Sara, Nemlaghi, Safaa, Bureau, Côme, Mora, Pierre, De Sarcus, Martin, Clovet, Olivier, Duceau, Baptiste, Grisot, Paul Henri, Pari, Marie Hélène, Arzoine, Jérémy, Clarac, Ulrich, Boutolleau, David, Raux, Mathieu, Delemazure, Julie, Faure, Morgane, Decavele, Maxens, Morawiec, Elise, Mayaux, Julien, Demoule, Alexandre, Dres, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351645/
https://www.ncbi.nlm.nih.gov/pubmed/32653015
http://dx.doi.org/10.1186/s13054-020-03117-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351645/
https://www.ncbi.nlm.nih.gov/pubmed/32653015
http://dx.doi.org/10.1186/s13054-020-03117-9

Ejemplares similares